8
540 Zhao et al.
Asian J. Chem.
nanoparticles as catalysts for the synthesis of 1,5-benzodia-
zepines. The effectiveness of the process was studied by
comparing the results obtained with and without catalyst under
normal conditions.
2,3-Dihydro-2-methyl-2,4-diphenyl-1H-1,5-benzodia-
-1
zepine: (entry 1) IR (KBr, νmax, cm ): 3277 (sec N-H), 3061
(aromatic C-H), 2972 (aliphatic C-H), 1559 (aromatic C=C);
1
H NMR (CDCl
.2 (d, 1H, -CH), δ 6.8-7.7 (m, 14H, ArH); Anal. Calcd. for
C H N : C, 84.58; H, 6.45; N, 8.97; found: C, 84.60; H, 6.42;
3
): δ 1.8 (s, 3H, -CH ), δ 3.1 (d, 1H, -CH), δ
3
3
R1
H
2
2
20
2
R
NH2
N
N
R
2
O
R
ZnO NPs
N, 8.94.
2,2,4-Trimethyl-2,3-dihydro-1H-1,5-benzodiazepine:
R3
NH2
R
1
R
2
R
4
-1
R = H, CH3, NO2
(entry 3) IR (KBr, νmax, cm ): 3292 (NH), 2955 (aromatic CH),
1
1
632 (alkene C=C), 1474 (aromatic C=C); H NMR (CDCl
δ 1.3 (s, 6H, -C(CH ), δ 2.2 (s, 2H, -CH ), δ 2.4 (s, 3H,
), δ 6.7-7.2 (m, 4H, ArH); Anal. Calcd. for C12 : C,
6.55; H, 8.57; N, 14.88; found: C, 76.51; H, 8.52; N, 14.92.
0-Spirocycloheptan-6,7,8,9,10,10a,11,12-octahydro-
benzo[b]cyclohepta[e][1,4] diazepine: (entry 6) IR (KBr, νmax
3
):
(
)
n
R
NH
NH
2
2
R
1
3
)
2
2
H
N
O
ZnO NPs
R
R2
-
CH
3
16 2
H N
R
3
7
n= 2,3
N
R
4
n
R = H, CH3, NO
2
1
Scheme-I:Chemical reaction for the synthesis of 2,3-dihydro-1H-1,5-
,
benzodiazepines using zinc oxide nanoparticles
-1
cm ): 3328 (sec. NH), 3060 (aromatic CH), 2923 (alkene CH),
2
852 (alkane CH), 1617 (imine C=N), 1493 (aromatic C=C).
1
EXPERIMENTAL
H NMR (CDCl
H, -CH ), δ 2.8 (m, 1H, -CH), δ 6.6-7.4 (m, 4H, ArH); Anal.
Calcd. for C20 : C, 81.03; H, 9.52; N, 9.45; found: C,
1.15; H, 9.56; N, 9.54.
,2,4-Trimethyl-2,3-dihydro-8-methyl-1H-1,5-benzo-
3
): δ 1.5-2.4 (m, 21H, -CH
2
, -NH), δ 2.6 (m,
2
2
The melting points were determined on Veego-program-
mable melting point apparatus (microprocessor based) and are
1
uncorrected. Proton ( H) nuclear magnetic resonance spectra
28 2
H N
8
2
were obtained using BruckerAC-400 F, 400 MHz spectrometer
and are reported in parts per million (ppm), downfield from
tetramethylsilane (TMS) as internal standard Infrared (IR)
spectra were obtained with Perkin Elmer 882 Spectrum and
-1
diazepine: (entry 7) IR (KBr, νmax, cm ): 3454 (sec. NH), 2924
(
(
(
-
aromatic CH), 2854 (alkane CH), 1437 (aromatic C=C), 1237
1
C-N), 946 (1,2,4-substituted oop); H NMR (CDCl
s, 6H, -CH ), δ 1.35 (s, 3H, -CH ), δ 2.3 (m, 5H, -CH
CH), δ 6.5 (s, 1H, ArH), δ 6.79 (d, 1H, J = 7.4,ArH), δ 7.0 (d,
3
): δ 1.2
3
3
3
, -CH,
-1
RXI, FT-IR model using potassium bromide pellets (in cm ).
Elemental analyses for C, H, and N were performed on Perkin-
Elmer 2400 CHN elemental analyzer. X-ray diffraction of
nanoparticles were obtained using X-ray diffractometer,
1
H, J = 8.7, ArH); Anal. Calcd. for C13
.97; N, 13.85; found: C, 77.22; H, 8.91; N, 13.93.
1-Spirocyclohexane-2,3,4,10,11,11a-hexahydro-8-
methyl-1H-dibenzo[b,e][1,4] diazepine: (entry 9) IR (KBr,
18 2
H N : C, 77.17; H,
8
1
α
Panlytical X' pert Pro and (CuK ) radiations were used. TEM
images were obtained from Transmission Electron Microscope,
Hitachi H-7500 with 0.204 nm resolution and 6,00,000X
magnification. Reactions were monitored and the homogeneity
of the products was checked by TLC, which were prepared
with silica gel G and activated at 110 °C for 0.5 h. The plates
were developed by exposure to iodine vapours. Anhydrous
sodium sulphate was used as a drying agent.
-1
ν
max, cm ): 3351 (sec. NH), 2931 (alkene CH), 2857 (alkane
1
CH), 1633 (imine C=N), 1484 (aromatic C=C); H NMR
CDCl ): δ 1.7-2.5 (m, 18H, -CH ), δ 3.0 (s, 3H, -CH ), δ 3 (t,
H,-CH), δ 7.3-7.9 (m, 3H, ArH); Anal. Calcd. for C19
C, 80.80; H, 9.28; N, 9.92; found: C, 80.86; H, 9.34; N, 9.98.
,2,4-Trimethyl-2,3-dihydro-8-nitro-1H-1,5-benzodia-
(
3
2
3
1
26 2
H N :
2
-1
1
zepine: (entry 11) IR (KBr, νmax, cm ): 3280, 1645, 1600. H
NMR (CDCl ), δ ppm: δ 1.90 (s, 6H), 2.95 (s, 3H), 3.20 (s,
H), 7.18 (s, 1H), 8.0-8.10 (m, 1H), 8.5-8.9 (m, 1H); Anal.
Calcd. for C12 : C, 61.78; H, 6.48; N, 18.01 %; found:
C, 61.85; H, 6.66; N, 18.12 %.
Synthesis of ZnO nanoparticles: Zinc oxide nanopar-
ticles are prepared according to the literature method with some
3
2
19
modifications . Zinc acetate (9.10 g, 0.05 mol) and oxalic
acid (5.4 g, 0.06 mol) were combined by grinding in a mortar
15 3 2
H N O
2 4 2
for 1 h at room temperature. The formed ZnC O .2H O nano-
particles were subjected to microwave irradiation at 150 W
microwave power for 20 min to produced ZnO nanoparticles
under thermal decomposition conditions (yield: 75 %).
General procedure for the preparation of 2,3-dihydro-
RESULTS AND DISCUSSION
Initially we studied the influence of ZnO nanoparticles
for the synthesis of 1,5-benzodiazepine using o-phenylened-
iammine and acetophenone as a model reaction and varying
the amount of ZnO nanoparticles by simple optimization study
1H-1,5-benzodiazepines: o-Phenylenediamine (1 mmole) and
ZnO nanoparticles (20 mol % or 0.2 mmole) were crushed in
mortar and pestle to a fine powder and transferred to a china
dish and various ketone (2.2 mmole) was added. The reaction
mixture was heated on oil bath for 40-60 min with occasional
stirring. After completion of the reaction (monitored by TLC),
the reaction mixture was cooled to room temperature and ethyl
acetate was added. The catalyst was insoluble in ethyl acetate
and it could therefore be separated by a simple filtration. The
filtrate was collected, dried and residue was recrystallized from
ethanol or subjected to column chromatography to get the pure
products.
(
Table-1). The catalyst quantity was optimized to 20 mol % of
ZnO nanoparticles and excellent results (93 % yields) were
achieved. Similarly, another 1,5-benzodiazepine derivatives
have been synthesized from o-phenylenediamines and ketones
in 85-93 % yields (Table-2). It seems that high surface area
and better dispersion of nanoparticles in the reaction mixture
are reasons for better activities of ZnO nanoparticles. The
catalytic activity of ZnO nanoparticles was evident when no
product was obtained in the absence of the catalyst.